Clinical trial
Evaluation of 5-[123I]-A-85380 and SPECT Imaging in Individuals With Parkinsons…
NCT00397696 · Institute for Neurodegenerative Disorders, Other · Completed
Key facts
| NCT number | NCT00397696 |
|---|---|
| Title | Evaluation of 5-[123I]-A-85380 and SPECT Imaging in Individuals With Parkinsons Disease |
| Official title | Evaluation of 5-[123I]-A-85380 and SPECT Imaging as a Marker of Nicotinic Receptor Density in the Brain of Parkinson Disease Subjects |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Collaborators | United States Department of Defense U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | [123I] 5-IA |
| Enrollment | 9 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Jan 1, 2012 |
| First posted | Nov 9, 2006 |
| Last update posted | May 7, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: